These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33902604)

  • 41. Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells.
    Xia C; Liang S; He Z; Zhu X; Chen R; Chen J
    Eur J Pharmacol; 2018 Jul; 830():59-67. PubMed ID: 29704494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circular RNA Circ_0000442 acts as a sponge of MiR-148b-3p to suppress breast cancer via PTEN/PI3K/Akt signaling pathway.
    Zhang XY; Mao L
    Gene; 2021 Jan; 766():145113. PubMed ID: 32891771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis.
    Mak CS; Yung MM; Hui LM; Leung LL; Liang R; Chen K; Liu SS; Qin Y; Leung TH; Lee KF; Chan KK; Ngan HY; Chan DW
    Mol Cancer; 2017 Jan; 16(1):11. PubMed ID: 28095864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Curcumin sensitizes non-small cell lung cancer cell anoikis through reactive oxygen species-mediated Bcl-2 downregulation.
    Pongrakhananon V; Nimmannit U; Luanpitpong S; Rojanasakul Y; Chanvorachote P
    Apoptosis; 2010 May; 15(5):574-85. PubMed ID: 20127174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells.
    Gupta P; Gupta N; Fofaria NM; Ranjan A; Srivastava SK
    Cancer Lett; 2019 Feb; 442():68-81. PubMed ID: 30409762
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ERK/BCL-2 pathway in the resistance of pancreatic cancer to anoikis.
    Galante JM; Mortenson MM; Bowles TL; Virudachalam S; Bold RJ
    J Surg Res; 2009 Mar; 152(1):18-25. PubMed ID: 19062038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanistic attributes of S100A7 (psoriasin) in resistance of anoikis resulting tumor progression in squamous cell carcinoma of the oral cavity.
    Dey KK; Sarkar S; Pal I; Das S; Dey G; Bharti R; Banik P; Roy J; Maity S; Kulavi I; Mandal M
    Cancer Cell Int; 2015; 15():74. PubMed ID: 26225121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.
    Du L; Han XG; Tu B; Wang MQ; Qiao H; Zhang SH; Fan QM; Tang TT
    Cell Death Dis; 2018 Jun; 9(7):714. PubMed ID: 29915309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells.
    Peng YF; Shi YH; Ding ZB; Ke AW; Gu CY; Hui B; Zhou J; Qiu SJ; Dai Z; Fan J
    Autophagy; 2013 Dec; 9(12):2056-68. PubMed ID: 24157892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2.
    Wang LB; Feng L; He J; Liu B; Sun JG
    Math Biosci Eng; 2019 Jul; 16(6):6923-6933. PubMed ID: 31698596
    [No Abstract]   [Full Text] [Related]  

  • 51. Long Non-Coding RNA MAPK8IP1P2 Inhibits Lymphatic Metastasis of Thyroid Cancer by Activating Hippo Signaling
    Liu X; Fu Q; Bian X; Fu Y; Xin J; Liang N; Li S; Zhao Y; Fang L; Li C; Zhang J; Dionigi G; Sun H
    Front Oncol; 2020; 10():600927. PubMed ID: 33489905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing.
    Gordon MA; Babbs B; Cochrane DR; Bitler BG; Richer JK
    Mol Carcinog; 2019 Feb; 58(2):196-205. PubMed ID: 30294913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
    Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
    Ma D; Chen C; Wu J; Wang H; Wu D
    Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells.
    Sugimoto T; Bartholomeusz C; Tari AM; Ueno NT
    Breast Cancer Res; 2007; 9(4):R41. PubMed ID: 17612393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Knockdown of lncRNA-HOTAIR downregulates the drug-resistance of breast cancer cells to doxorubicin via the PI3K/AKT/mTOR signaling pathway.
    Li Z; Qian J; Li J; Zhu C
    Exp Ther Med; 2019 Jul; 18(1):435-442. PubMed ID: 31281438
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The chemopreventive isothiocyanate sulforaphane reduces anoikis resistance and anchorage-independent growth in non-small cell human lung cancer cells.
    Tsai JY; Tsai SH; Wu CC
    Toxicol Appl Pharmacol; 2019 Jan; 362():116-124. PubMed ID: 30365975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differences of time-dependent microRNA expressions in breast cancer cells.
    Bozkurt SB; Ozturk B; Kocak N; Unlu A
    Noncoding RNA Res; 2021 Mar; 6(1):15-22. PubMed ID: 33385103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. P-cadherin induces anoikis-resistance of matrix-detached breast cancer cells by promoting pentose phosphate pathway and decreasing oxidative stress.
    Sousa B; Pereira J; Marques R; Grilo LF; Pereira SP; Sardão VA; Schmitt F; Oliveira PJ; Paredes J
    Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165964. PubMed ID: 32920119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LncRNA SNHG5 affects cell proliferation, metastasis and migration of colorectal cancer through regulating miR-132-3p/CREB5.
    Zhang M; Li Y; Wang H; Yu W; Lin S; Guo J
    Cancer Biol Ther; 2019; 20(4):524-536. PubMed ID: 30395767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.